In a groundbreaking study published in the in Proceedings of the National Academy of Sciences (PNAS), scientists at Pacific ...

The Company finishes 2025 with strong Q4 performance, expects 20-22% revenue growth in 2026, and promotes Ross Muken to ...

Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and fiscal year ended December 31, 2025. "2025 was ...

Parkinson's disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of ...

A research team led by Václav Vopálenský and Martin Pospíšek from the Faculty of Science, Charles University, has discovered ...

Genetic testing on embryos is more sophisticated and accessible than ever—and it’s now being sold as a way to let parents pick their future baby’s best traits.

Thanks to genetic science, gene editing, and techniques like cloning, it’s now possible to move DNA through time, studying ...

A groundbreaking cattle genome has given researchers their clearest look yet at what makes Wagyu beef so special. By ...

After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...

A large genetic screen has revealed how stem cells transform into brain cells, exposing hundreds of genes that make this ...

Texas A&M AgriLife faculty, staff and graduate students earn Vice Chancellor’s Awards in Excellence honors at Texas A&M ...

EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), a technology-based company with a well-established laboratory services business and a therapeutic development ...